US4261982A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic composition
Assignee: Procter and Gamble Co
•
Filing: 1978-10-25
•
Granted: 1981-04-14
•
Expires: 1998-10-25
Abstract
Abstract Zinc compounds, especially zinc salts of carboxylic acids, react with erythromycin to provide zinc erythromycin. Topical compositions containing zincerythromycin are especially useful as a topical treatment for acne.
Inventors
- 👤 Wilmer L. Luedders
- 👤 Richard E. Willins
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 13:48
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K8/00; A61K8/18; A61K8/19; A61K8/27; A61K8/30; A61K8/60; A61K8/602; A61Q; A61Q19/00; C; C07; C07H; C07H17/00; C07H17/04; C07H17/08
Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
49 words
A process for preparing zinc erythromycin by admixing a zinc compound soluble in said admixture selected from toxicologically-acceptable zinc salts of carboxylic acids and amino acids with erythromycin base in a solid or liquid reaction medium wherein said zinc compound and erythromycin base can be admixed in reactive form.
Claim 2
Dependent Claim
49 words
A process for preparing zinc erythromycin by admixing a zinc compound soluble in said admixture selected from toxicologically-acceptable zinc salts of carboxylic acids and amino acids with erythromycin base in a solid or liquid reaction medium wherein said zinc compound and erythromycin base can be admixed in reactive form.
Claim 3
Dependent Claim
12 words
A process according to claim 1 wherein the reaction medium is ethanol.
Claim 4
Dependent Claim
21 words
A process according to claim 1 wherein the zinc compound is a salt of a C 2 -C 8 carboxylic acid.
Claim 5
Dependent Claim
30 words
A process according to claim 1 for preparing zinc erythromycin comprising admixing erythromycin base with a zinc compound selected from zinc acetate, zinc 2-ethyl hexanoate and zinc acetylacetonate in ethanol.
Claim 6
Dependent Claim
118 words
A composition for topical application to skin in the treatment of skin disorders and dermatoses of bacterial origin, comprising: (1) a minor proportion of a mixture of zinc compounds soluble in said composition, selected from toxicologically-acceptable zinc salts of C 1 -C 12 carboxylic acids, zinc salts of amino acids, zinc acetylacetonate, zinc chloride, zinc bromide, zinc citrate, zinc maleate, zinc benzoate, zinc phosphate, zinc sulfate, or mixtures thereof, together with erythromycin compounds, selected from erythromycin base, erythromycin estolate, erythromycin glucoheptonate, erythromycin lactobionate, erythromycin propionate, erythromycin stearate, erythromycin ethyl succinate, and mixtures thereof, wherein the ratio of zinc compound to erythromycin compound is from about 1:10 to about 10:1; and (2) the balance comprising a pharmaceutically-acceptable topical carrier.
Claim 7
Dependent Claim
118 words
A composition for topical application to skin in the treatment of skin disorders and dermatoses of bacterial origin, comprising: (1) a minor proportion of a mixture of zinc compounds soluble in said composition, selected from toxicologically-acceptable zinc salts of C 1 -C 12 carboxylic acids, zinc salts of amino acids, zinc acetylacetonate, zinc chloride, zinc bromide, zinc citrate, zinc maleate, zinc benzoate, zinc phosphate, zinc sulfate, or mixtures thereof, together with erythromycin compounds, selected from erythromycin base, erythromycin estolate, erythromycin glucoheptonate, erythromycin lactobionate, erythromycin propionate, erythromycin stearate, erythromycin ethyl succinate, and mixtures thereof, wherein the ratio of zinc compound to erythromycin compound is from about 1:10 to about 10:1; and (2) the balance comprising a pharmaceutically-acceptable topical carrier.
Claim 8
Dependent Claim
10 words
A composition according to claim 5 which is substantially water-free.
Claim 9
Dependent Claim
11 words
A composition according to claim 6 which is substantially ethanol free.
Claim 10
Dependent Claim
20 words
A composition according to claim 6 which comprises from about 0.001% to about 25% by weight of the active agent.
Claim 11
Dependent Claim
21 words
A composition according to claim 5 wherein the zinc compound is selected from zinc acetate, zinc 2-ethyl hexanoate and zinc acetylacetonate.
Claim 12
Dependent Claim
30 words
A method for treating skin disorders and dermatoses of bacterial origin comprising applying topically thereto at an afflicted situs a safe and effective amount of the composition of claim 9.
Claim 13
Dependent Claim
30 words
A method for treating skin disorders and dermatoses of bacterial origin comprising applying topically thereto at an afflicted situs a safe and effective amount of the composition of claim 7.
Claim 14
Independent Claim
21 words
A method for promoting wound healing comprising topically applying a safe and effective amount of zinc erythromycin to the afflicted situs.
Claim 15
Independent Claim
21 words
A method for promoting wound healing comprising topically applying a safe and effective amount of zinc erythromycin to the afflicted situs.
Claim 16
Independent Claim
71 words
A method for systemically treating skin disorders and dermatoses of bacterial origin and systemic bacterial infections and for promoting wound healing comprising administering systemically to a patient in need of such treatment a safe and effective amount of zinc erythromycin or a mixture of a zinc compound selected from toxicologically-acceptable zinc salts and an erythromycin compound selected from erythromycin base, salts of erythromycin base with acids, and ester derivatives of erythromycin.
Claim 17
Independent Claim
71 words
A method for systemically treating skin disorders and dermatoses of bacterial origin and systemic bacterial infections and for promoting wound healing comprising administering systemically to a patient in need of such treatment a safe and effective amount of zinc erythromycin or a mixture of a zinc compound selected from toxicologically-acceptable zinc salts and an erythromycin compound selected from erythromycin base, salts of erythromycin base with acids, and ester derivatives of erythromycin.
Claim 18
Dependent Claim
23 words
A method for treating acne comprising applying topically at an afflicted situs a safe and effective amount of the composition of claim 6.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1984-04-13 | 1984-10-13 | 1985-04-14 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1988-04-13 | 1988-10-13 | 1989-04-14 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1992-04-13 | 1992-10-13 | 1993-04-14 | $7700.00 | Window Closed / Lapsed |